| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 32,355 | 35,198 | 35,970 | 44,549 | | Cost of Revenue | (24,071) | 14,375 | 9,696 | (18,157) | | | Gross Profit | 56,426 | 20,823 | 26,274 | 62,706 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 49,301 | 12,114 | 17,324 | 45,918 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,062 | 1,115 | 1,129 | 1,110 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,063 | 7,594 | 7,821 | 15,678 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,063 | 7,594 | 7,821 | 15,678 | | Interest Expense |
-
|
-
|
-
| 3,166 | | Income Before Tax | 6,063 | 7,594 | 7,821 | 12,512 | | Income Tax Expense | 2,366 | 2,913 | 3,141 | 4,896 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,697 | 4,681 | 4,680 | 7,616 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,697 | 4,681 | 4,680 | 7,616 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,697 | $4,681 | $4,680 | $7,616 |
|
0.09% Nasdaq 
0.37%
Income Statement
